The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis

被引:10
|
作者
Kuehnlein, Peter [2 ,3 ]
Jung, Hans [1 ]
Farkas, Melinda [1 ]
Keskitalo, Salla [1 ]
Ineichen, Benjamin [1 ]
Jelcic, Ilijas [1 ]
Petersen, Jens [1 ]
Semmler, Alexander [1 ]
Weller, Michal [1 ]
Ludolph, Albert Christian [2 ]
Linnebank, Michael [1 ]
机构
[1] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland
[2] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany
[3] Schoen Klin Bad Staffelstein, Dept Neurol, Bad Staffelstein, Germany
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2011年 / 12卷 / 02期
关键词
Amyotrophic lateral sclerosis; methylenetetrahydrofolate reductase; homocysteine; SOD; METHYLENETETRAHYDROFOLATE REDUCTASE; GENETIC-VARIANTS; HOMOCYSTEINE; METABOLISM; MUTATIONS;
D O I
10.3109/17482968.2010.536985
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hyperhomocysteinemia is a risk factor for neurodegeneration, and binding of copper by homocysteine is a putative underlying mechanism. As mutations of the copper-dependent superoxide dismutase are observed in familial ALS, we tested whether genetic variants with influence on homocysteine metabolism are associated with ALS. We compared the frequency of seven variants of genes involved in homocysteine metabolism in 162 patients with sporadic ALS and 162 controls who did not significantly differ in age (t == 1.27, p == 0.205) and gender (chi chi<SU2</SU == 2.48, p == 0.115) using binary regression analysis. Results showed that the variant MTHFR c.677C > T was significantly associated with ALS, i.e. the T-allele was more frequent among patients. Explorative regression analysis revealed that MTHFR c.677C > T was not associated with spinal ALS, but with bulbar onset: CC/CT/TT in patients 0.33/0.51/0.16 versus 0.50/0.44/0.06 in controls; Wald == 5.73, p == 0.017. In addition, DHFR c.594++59del19bp was not associated with spinal, but with bulbar onset: del,del/del,ins/ins,ins in patients 0.16/0.67/0.18 versus 0.11/0.52/0.37 in controls; Wald == 5.02, p == 0.025. The other variants did not show significant associations. In summary, the variants MTHFR c.677C > T and DHFR c.594++59del19bp are involved in homocysteine metabolism. Homocysteine is neurotoxic and binds copper. Thus, the individual variability of homocysteine metabolism, e.g. due to genetic variants, may contribute to the vulnerability of ALS.
引用
收藏
页码:136 / 139
页数:4
相关论文
共 50 条
  • [21] 5,10-Methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTRR), and methionine synthase reductase (MTR) gene polymorphisms and adult meningioma risk
    Zhang, Jun
    Zhou, Yan-Wen
    Shi, Hua-Ping
    Wang, Yan-Zhong
    Li, Gui-Ling
    Yu, Hai-Tao
    Xie, Xin-You
    JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (02) : 233 - 239
  • [22] Strain-Specific Defects in Testicular Development and Sperm Epigenetic Patterns in 5,10-Methylenetetrahydrofolate Reductase-Deficient Mice
    Chan, Donovan
    Cushnie, Duncan W.
    Neaga, Oana R.
    Lawrance, Andrea K.
    Rozen, Rima
    Trasler, Jacquetta M.
    ENDOCRINOLOGY, 2010, 151 (07) : 3363 - 3373
  • [23] Impact of 5,10-methylenetetrahydrofolate reductase gene polymorphism on neural tube defects Laboratory investigation
    Harisha, Poomagame Narasimhamurthy
    Devi, B. Indira
    Christopher, Rita
    Kruthika-Vinod, Tumkur Puttasiddhappa
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2010, 6 (04) : 364 - 367
  • [24] Localization of Folate Metabolic Enzymes, Methionine Synthase and 5,10-Methylenetetrahydrofolate Reductase in Human Placenta
    Shin, Jung-a
    Kim, Young-ju
    Park, Hyesook
    Kim, Hee-kyoung
    Lee, Hwa-young
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2014, 78 (04) : 259 - 265
  • [25] 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects
    Ou, CY
    Stevenson, RE
    Brown, VK
    Schwartz, CE
    Allen, WP
    Khoury, MJ
    Rozen, R
    Oakley, GP
    Adams, MJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 63 (04): : 610 - 614
  • [26] Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition
    Froese, D. Sean
    Kopec, Jolanta
    Rembeza, Elzbieta
    Bezerra, Gustavo Arruda
    Oberholzer, Anselm Erich
    Suormala, Terttu
    Lutz, Seraina
    Chalk, Rod
    Borkowska, Oktawia
    Baumgartner, Matthias R.
    Yue, Wyatt W.
    NATURE COMMUNICATIONS, 2018, 9
  • [27] RETRACTED: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults (retracted article)
    Liu, Ping
    Zhang, Min
    Xie, Xing
    Jin, Jie
    Holman, C. D'Arcy J.
    TUMOR BIOLOGY, 2016, 37 (03) : 3265 - 3275
  • [28] 5,10-methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women
    Fohr, IP
    Prinz-Langenohl, R
    Brönstrup, A
    Bohlmann, AM
    Nau, H
    Berthold, HK
    Pietrzik, K
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (02) : 275 - 282
  • [29] 5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia (ALL)
    Kuzelicki, Natasa Karas
    Milek, Miha
    Jazbec, Janez
    Mlinaric-Rascan, Irena
    LEUKEMIA RESEARCH, 2009, 33 (10) : 1344 - 1348
  • [30] Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin
    Kang, Sang Yoon
    Lee, Sung Jun
    Hong, Seung Ho
    Chung, Yoon Kyu
    Oh, Hyun Soo
    Kim, Sug Won
    Yim, Dong Jin
    Kim, Nam Keun
    MOLECULAR MEDICINE REPORTS, 2010, 3 (05) : 741 - 747